Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Atomic Energy of Canada Limited
The Atomic Energy of Canada Limited (AECL) is the organization established by the Canadian government primarily for the purpose of commercializing the Canada Deuterium and Uranium (CANDU) nuclear reactor system. Reviews past performance of AECL, its weak organizational structures and inability to adapt to the world market, past political constraints and political outlooks influencing management practices, and failures of CANDU marketing. This study provides a new cost/benefit analysis in order to establish a measure of AECL's success and to provide a basis for considering further public investment.
Canada Enters the Nuclear Age
Written by sixteen of Canada's pioneering nuclear scientists, the book focuses on Canada's nuclear program at AECL's laboratories at Chalk River, Ontario, and Whiteshell, Manitoba, between the years 1943 and 1985. Topics include the organization and operations of AECL's laboratories, nuclear safety and radiation protection, radioisotopes, basic research, development of the CANDU reactor, and the management of radioactive wastes. As well as providing a valuable historical perspective on Canadian science, Canada Enters the Nuclear Age offers useful guidance for innovative scientific development in the future, a future that will depend on developing and nurturing technically sophisticated industry.
List of Publications
None
Medical Isotope Production Without Highly Enriched Uranium
This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply.
